Zetterberg H - Search Results

1

A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer's disease.

Bruno D, Jauregi Zinkunegi A, Kollmorgen G, Carboni M, Wild N, Carlsson C, Bendlin B, Okonkwo O, Chin N, Hermann BP, Asthana S, Blennow K, Langhough R, Johnson SC, Pomara N, Zetterberg H, Mueller KD. Bruno D, et al. Among authors: zetterberg h. J Clin Exp Neuropsychol. 2023 Oct;45(8):763-769. doi: 10.1080/13803395.2023.2240060. Epub 2023 Aug 12. J Clin Exp Neuropsychol. 2023. PMID: 37571873 Free PMC article.

2

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Zetterberg H, Wahlund LO, Blennow K. Zetterberg H, et al. Neurosci Lett. 2003 Nov 27;352(1):67-9. doi: 10.1016/j.neulet.2003.08.011. Neurosci Lett. 2003. PMID: 14615052

3

Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease.

Zetterberg H, Andreasen N, Blennow K. Zetterberg H, et al. Neurosci Lett. 2004 Sep 2;367(2):194-6. doi: 10.1016/j.neulet.2004.06.001. Neurosci Lett. 2004. PMID: 15331151

4

Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results.

Zetterberg H, Blennow K. Zetterberg H, et al. Neurol Sci. 2004 Dec;25(5):301-2. doi: 10.1007/s10072-004-0358-5. Neurol Sci. 2004. PMID: 15624089 No abstract available.

5

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, Wahlund LO, Blennow K. Johansson A, et al. Among authors: zetterberg h. Dement Geriatr Cogn Disord. 2005;20(6):367-74. doi: 10.1159/000088634. Epub 2005 Sep 29. Dement Geriatr Cogn Disord. 2005. PMID: 16192727

6

Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

Blennow K, Johansson A, Zetterberg H. Blennow K, et al. Among authors: zetterberg h. Int J Mol Med. 2005 Dec;16(6):1147-9. Int J Mol Med. 2005. PMID: 16273298

7

Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.

Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Hansson O, et al. Among authors: zetterberg h. Lancet Neurol. 2006 Mar;5(3):228-34. doi: 10.1016/S1474-4422(06)70355-6. Lancet Neurol. 2006. PMID: 16488378

8

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

Portelius E, Westman-Brinkmalm A, Zetterberg H, Blennow K. Portelius E, et al. Among authors: zetterberg h. J Proteome Res. 2006 Apr;5(4):1010-6. doi: 10.1021/pr050475v. J Proteome Res. 2006. PMID: 16602710

9

Pinpointing plaques with PIB.

Blennow K, Zetterberg H. Blennow K, et al. Among authors: zetterberg h. Nat Med. 2006 Jul;12(7):753-4; discussion 754. doi: 10.1038/nm0706-753. Nat Med. 2006. PMID: 16829927 No abstract available.

10

Plasma Abeta in Alzheimer's disease--up or down?

Zetterberg H, Blennow K. Zetterberg H, et al. Lancet Neurol. 2006 Aug;5(8):638-9. doi: 10.1016/S1474-4422(06)70503-8. Lancet Neurol. 2006. PMID: 16857565 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,420 results

Search Page

Filters